Hematologic malignancies: New developments and future treatments

被引：36

作者：

Cheson, BD ^{[1
]}

机构：

[1] Clin Invest Branch, NCI, Bethesda, MD USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 04期

关键词：

D O I：

10.1053/sonc.2002.34878

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：33 / 45

页数：13

共 111 条

[1]

Adams J, 1999, CANCER RES, V59, P2615

[2] Novel inhibitors of the proteasome and their therapeutic use in inflammation [J].

Adams, J ;

Stein, R .

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 31, 1996, 31 :279-288

[3] Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein [J].

Akao, Y ;

Mizoguchi, H ;

Kojima, S ;

Naoe, T ;

Ohishi, N ;

Yagi, K .

BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (04) :1055-1060

[4]

Alas S, 2001, CANCER RES, V61, P5137

[5] Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].

Alizadeh, AA ;

Eisen, MB ;

Davis, RE ;

Ma, C ;

Lossos, IS ;

Rosenwald, A ;

Boldrick, JG ;

Sabet, H ;

Tran, T ;

Yu, X ;

Powell, JI ;

Yang, LM ;

Marti, GE ;

Moore, T ;

Hudson, J ;

Lu, LS ;

Lewis, DB ;

Tibshirani, R ;

Sherlock, G ;

Chan, WC ;

Greiner, TC ;

Weisenburger, DD ;

Armitage, JO ;

Warnke, R ;

Levy, R ;

Wilson, W ;

Grever, MR ;

Byrd, JC ;

Botstein, D ;

Brown, PO ;

Staudt, LM .

NATURE, 2000, 403 (6769) :503-511

[6]

Ansell SM, 2001, BLOOD, V98, p604A

[7]

Ansell SM, 1999, BLOOD, V94, p86A

[8]

Ansell SM, 2000, BLOOD, V96, p577A

[9] Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma:: Results from a prospective, multicenter trial with double randomization [J].

Arranz, R ;

García-Alfonso, P ;

Sobrino, P ;

Zamora, P ;

Carrión, R ;

García-Laraña, J ;

Pérez, G ;

López, J ;

Lavilla, E ;

Lozano, M ;

Rayón, C ;

Colomer, R ;

Barón, MG ;

Flores, E ;

Pérez-Manga, G ;

Fernández-Rañada, JM .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1538-1546

[10] Interferon alpha 2b as maintenance therapy in low grade malignant lymphoma improves duration of remission and survival [J].

Aviles, A ;

Duque, G ;

Talavera, A ;

Guzman, R .

LEUKEMIA & LYMPHOMA, 1996, 20 (5-6) :495-499

← 1 2 3 4 5 6 7 8 9 10 →